Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00606671
Recruitment Status : Completed
First Posted : February 4, 2008
Last Update Posted : February 4, 2008
Sponsor:
Collaborators:
Diabetesforeningen
Danish Hospital foundation for medical research. region Copenhagen, The Faroe Islands and Greenland.
Aage Bangs Fond
Information provided by:
Hvidovre University Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The scope of the study was to investigate different metabolic aspects that may lead to or are a consequence of insulin resistance in premenopausal women with polycystic ovary syndrome (PCOS). We use gold standard methods for evaluation of insulin resistance. We take muscle and fat biopsies for investigation of gene expression of different cytokines associated with insulin resistance. We investigate the incretin hormones GIP and GLP-1. These two hormones play a central role in glycemic control, and diabetic subjects are known to have alterations in their incretin hormones. The incretin hormones have not previously been investigated in women with PCOS.

Condition or disease
Polycystic Ovary Syndrome

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 65 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Insulin Resistance in Polycystic Ovary Syndrome (PCOS)
Study Start Date : February 2004
Actual Primary Completion Date : May 2006
Actual Study Completion Date : May 2006

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
1
lean control women without PCOS
2
lean women with PCOS
3
Obese control women without PCOS
4
Obese women with PCOS
1xx - 04 LC
lean control women
1xx-04 LP
lean women with PCOS
1xx-04 OC
obese control women
1xx-04 OP
obese women with PCOS


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. insulin resistance [ Time Frame: 2004-2006 ]

Secondary Outcome Measures :
  1. gene expression of cytokines in fatty tissue [ Time Frame: 2004-2006 ]

Biospecimen Retention:   Samples With DNA
Fat and muscle biopsies

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 38 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
lean and obese women with and without PCOS
Criteria

Inclusion Criteria:

  • Premenopausal women that meet the Rotterdam criteria for PCOS (BMI < 40)
  • Age and BMI matched control women that do not have any signs or symptoms of PCOS

Exclusion Criteria:

  • BMI > 40. mani fest diabetes or other known diseases
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00606671


Locations
Layout table for location information
Denmark
Dpt. of Obstetrics and Gynaecology, Copenhagen University Hospital, Hvidovre
Hvidovre, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
Diabetesforeningen
Danish Hospital foundation for medical research. region Copenhagen, The Faroe Islands and Greenland.
Aage Bangs Fond
Investigators
Layout table for investigator information
Principal Investigator: Pernille Fog Svendsen, MD Dpt. of Obstetrics and Gynaecology, Copenhagen University Hospital, Hvidovre
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Lisbeth Nilas, Dpt. of Obstetrics and Gynaecology, Copenhagen University Hospital, Hvidovre
ClinicalTrials.gov Identifier: NCT00606671    
Other Study ID Numbers: PCOS
First Posted: February 4, 2008    Key Record Dates
Last Update Posted: February 4, 2008
Last Verified: January 2008
Keywords provided by Hvidovre University Hospital:
polycystic ovary syndrome (PCOS)
Additional relevant MeSH terms:
Layout table for MeSH terms
Polycystic Ovary Syndrome
Syndrome
Disease
Pathologic Processes
Ovarian Cysts
Cysts
 Neoplasms
Ovarian Diseases
Adnexal Diseases
Gonadal Disorders
Endocrine System Diseases